Track the 메디쎄이 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 메디쎄이 has recorded 3 reports. Market capitalisation: €41.2bn. The latest transaction was disclosed on 27 March 2026 (Purchase). Among the most active insiders: 동화약품. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
메디쎄이是一家在XKRX市场上市的医疗保健和制药公司。该公司专注于为医疗领域开发创新解决方案。